IRIS

FAGONE, PAOLO FABRIZIO

FAGONE, PAOLO FABRIZIO  

SCIENZE BIOMEDICHE E BIOTECNOLOGICHE  

Mostra records
Risultati 1 - 20 di 133 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autore(i) File
). NO-hybridized protease inhibitors as a new class of anticancer compounds. Saquinavir-NO as prototypical example?. 1-gen-2012 Nicoletti, Ferdinando; Maksimovic Ivanic, Danijela; Mijatovic, Sanja; Fagone, Paolo; Zocca Mai, Britt; Stosic Grujicic, Stanislava file da validare
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 1-gen-2012 Nicoletti, Ferdinando; Philippens, I; Fagone, P; Ahlem, Cn; Reading, Cl; Frincke, Jm; Auci, D. L.
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 1-gen-2021 Lombardo, Salvo Danilo; Basile, Maria Sofia; Ciurleo, Rosella; Bramanti, Alessia; Arcidiacono, Antonio; Mangano, Katia; Bramanti, Placido; Nicoletti, Ferdinando; Fagone, Paolo
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 1-gen-2015 Donia, Marco; Andersen, Rikke; Kjeldsen Julie, W; Fagone, Paolo; Munir, Shamaila; Nicoletti, Ferdinando; Andersen Mads, Hald; Thor Straten, Per; Svane Inge, Marie
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 1-gen-2014 Fagone, P; Mangano, KATIA DOMENICA; Mammana, S; Quattrocchi, C; Magro, Gaetano Giuseppe; Coco, Marinella; Imene, S; Di Marco, R; Nicoletti, Ferdinando
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 1-gen-2017 Donia, M; Harbst, K; van Buuren, M; Kvistborg, P; Lindberg, Mf; Andersen, R; Idorn, M; Munir Ahmad, S; Ellebæk, E; Mueller, A; Fagone, P; Nicoletti, F; Libra, M; Lauss, M; Hadrup, Sr; Schmidt, H; Andersen, Mh; Thor Straten, P; Nilsson, Ja; Schumacher, Tn; Seliger, B; Jönsson, G; Svane, I. M.
Advances in targeting signal transduction pathways. 1-gen-2012 Mccubrey, Ja; Steelman, Ls; Chappell, Wh; Sun, L; Davis, Nm; Abrams, Sl; Franklin, Ra; Cocco, L; Evangelisti, C; Chiarini, F; Martelli, Am; Libra, Massimo; Candido, S; Ligresti, G; Malaponte, G; Mazzarino, Maria Clorinda; Fagone, P; Donia, M; Nicoletti, Ferdinando; Polesel, J; Talamini, R; Basecke, J; Mijatovic, S; Maksimovic Ivanic, D; Milella, M; Tafuri, A; Dulinska Litewka, J; Laidler, P; D'Assoro, Ab; Drobot, L; Umezawa, K; Montalto, G; Cervello, M; Demidenko, Zn
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 1-gen-2021 Fagone, Paolo; Mangano, Katia; Di Marco, Roberto; Reyes-Castillo, Zyanya; Muñoz-Valle, José Francisco; Nicoletti, Ferdinando
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 1-gen-2023 Alexova, Ralitza; Alexandrova, Simona; Dragomanova, Stela; Kalfin, Reni; Solak, Ayten; Mehan, Sidharth; Petralia, Maria Cristina; Fagone, Paolo; Mangano, Katia; Nicoletti, Ferdinando; Tancheva, Lyubka
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 1-gen-2013 Saksida, Tamara; Miljkovic, Djordje; Timotijevic, Gordana; Stojanovic, Ivana; Mijatovic, Sanja; Fagone, Paolo; Mangano, KATIA DOMENICA; Mammana, Santa; Farina, Claudio; Ascione, Ester; Maiello, Valentina; Nicoletti, Ferdinando; Stosic Grujicic, Stanislava
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 1-gen-2012 Donia, M; Fagone, P; Nicoletti, Ferdinando; Andersen, Rs; Høgdall, E; Straten, Pt; Andersen, Mh; Svane, I. M. file da validare
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 1-gen-2012 Nicoletti, Ferdinando; Fagone, P.; Mangano, K.; Motterlini, R.; Meroni, P. L. file da validare
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 1-gen-2015 Fagone, P; Mangano, KATIA DOMENICA; Mammana, S; Cavalli, E; Di Marco, R; Barcellona, Ml; Salvatorelli, L; Magro, Gaetano Giuseppe; Nicoletti, Ferdinando
Cathepsin A levels in CD4+ T cells from HIV-positive patients 1-gen-2016 DI ROSA, MICHELINO DANIELE ANTONIO; Fagone, P; Pinzone, M; Nunnari, G.
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 1-gen-2016 Nunnari, G; Fagone, P; Condorelli, F; Nicoletti, Ferdinando; Malaguarnera, Lucia; DI ROSA, MICHELINO DANIELE ANTONIO
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 1-gen-2022 Fagone, Paolo; Mangano, Katia; Martino, Gabriella; Quattropani, Maria Catena; Pennisi, Manuela; Bella, Rita; Fisicaro, Francesco; Nicoletti, Ferdinando; Petralia, Maria Cristina
Characterization of the pathophysiological role of CD47 in uveal melanoma 1-gen-2019 Petralia, M. C.; Mazzon, E.; Fagone, P.; Russo, A.; Longo, A.; Avitabile, T.; Nicoletti, F.; Reibaldi, M.; Basile, M. S.
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 1-gen-2012 Fagone, P; Donia, Marco; Mangano, K; Quattrocchi, C; Mammana, S; Coco, M; Libra, M; Mccubrey, Ja; Nicoletti, F file da validare
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 1-gen-2013 Fagone, Paolo; Donia, Marco; Mangano, KATIA DOMENICA; Quattrocchi, Cinzia; Mammana, Santa; Coco, Marinella; Libra, Massimo; McCubrey James, A.; Nicoletti, Ferdinando
Comprehensive analysis of rna-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder 1-gen-2020 Rahman, M. R.; Petralia, M. C.; Ciurleo, R.; Bramanti, A.; Fagone, P.; Shahjaman, M.; Wu, L.; Sun, Y.; Turanli, B.; Arga, K. Y.; Islam, M. R.; Islam, T.; Nicoletti, F.